California State Teachers Retirement System (CalSTRS)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$65M Buy
199,316
+1,873
+0.9% +$611K 0.07% 242
2025
Q1
$53.3M Buy
197,443
+1,081
+0.6% +$292K 0.07% 270
2024
Q4
$46.2M Buy
196,362
+5,037
+3% +$1.19M 0.05% 307
2024
Q3
$52.6M Sell
191,325
-2,269
-1% -$624K 0.06% 286
2024
Q2
$47M Buy
193,594
+2,176
+1% +$529K 0.06% 291
2024
Q1
$28.6M Sell
191,418
-160
-0.1% -$23.9K 0.04% 404
2023
Q4
$36.7M Buy
191,578
+1,347
+0.7% +$258K 0.05% 327
2023
Q3
$33.7M Sell
190,231
-8,367
-4% -$1.48M 0.05% 327
2023
Q2
$37.7M Sell
198,598
-4,664
-2% -$886K 0.05% 325
2023
Q1
$40.7M Buy
203,262
+1,531
+0.8% +$307K 0.06% 306
2022
Q4
$47.9M Buy
201,731
+3,380
+2% +$803K 0.08% 261
2022
Q3
$39.7M Sell
198,351
-1,620
-0.8% -$324K 0.07% 280
2022
Q2
$29.2M Buy
199,971
+758
+0.4% +$111K 0.05% 366
2022
Q1
$32.5M Sell
199,213
-10,519
-5% -$1.72M 0.04% 382
2021
Q4
$35.6M Buy
209,732
+4,340
+2% +$736K 0.04% 400
2021
Q3
$38.8M Sell
205,392
-4,439
-2% -$838K 0.05% 343
2021
Q2
$35.6M Sell
209,831
-6,445
-3% -$1.09M 0.04% 383
2021
Q1
$30.5M Buy
216,276
+1,020
+0.5% +$144K 0.04% 409
2020
Q4
$28M Buy
215,256
+4,599
+2% +$598K 0.04% 412
2020
Q3
$30.7M Buy
210,657
+6,789
+3% +$988K 0.05% 330
2020
Q2
$30.2M Buy
203,868
+16,660
+9% +$2.47M 0.05% 312
2020
Q1
$20.4M Buy
187,208
+655
+0.4% +$71.3K 0.04% 350
2019
Q4
$21.5M Buy
186,553
+13,037
+8% +$1.5M 0.04% 419
2019
Q3
$14M Buy
173,516
+1,775
+1% +$143K 0.03% 534
2019
Q2
$12.5M Buy
171,741
+19,192
+13% +$1.39M 0.02% 589
2019
Q1
$14.3M Buy
152,549
+8,213
+6% +$768K 0.03% 515
2018
Q4
$10.5M Buy
144,336
+1,399
+1% +$102K 0.02% 566
2018
Q3
$12.5M Buy
142,937
+14
+0% +$1.23K 0.02% 581
2018
Q2
$14.1M Buy
142,923
+3,496
+3% +$344K 0.03% 531
2018
Q1
$16.6M Sell
139,427
-2,852
-2% -$340K 0.04% 464
2017
Q4
$18.1M Buy
142,279
+12,605
+10% +$1.6M 0.04% 447
2017
Q3
$15.2M Sell
129,674
-5,221
-4% -$613K 0.03% 482
2017
Q2
$10.8M Sell
134,895
-14,395
-10% -$1.15M 0.02% 625
2017
Q1
$7.65M Sell
149,290
-6,800
-4% -$348K 0.02% 815
2016
Q4
$5.84M Sell
156,090
-4,200
-3% -$157K 0.01% 975
2016
Q3
$10.9M Buy
160,290
+1,400
+0.9% +$94.9K 0.02% 652
2016
Q2
$8.82M Buy
158,890
+397
+0.3% +$22K 0.02% 717
2016
Q1
$9.95M Buy
158,493
+20,201
+15% +$1.27M 0.02% 675
2015
Q4
$13M Buy
138,292
+2,196
+2% +$207K 0.03% 518
2015
Q3
$10.9M Buy
136,096
+587
+0.4% +$47.2K 0.03% 575
2015
Q2
$16.2M Buy
135,509
+2,891
+2% +$347K 0.04% 456
2015
Q1
$13.8M Buy
132,618
+8,256
+7% +$862K 0.03% 529
2014
Q4
$12.1M Buy
124,362
+1,127
+0.9% +$109K 0.03% 573
2014
Q3
$9.63M Buy
123,235
+1,981
+2% +$155K 0.02% 641
2014
Q2
$7.66M Buy
121,254
+15,500
+15% +$979K 0.02% 775
2014
Q1
$7.1M Buy
105,754
+500
+0.5% +$33.6K 0.02% 781
2013
Q4
$6.77M Buy
105,254
+700
+0.7% +$45K 0.02% 787
2013
Q3
$6.69M Buy
104,554
+3,281
+3% +$210K 0.02% 751
2013
Q2
$3.14M Buy
+101,273
New +$3.14M 0.01% 1108